Sign in
Hypoxia—implications for pharmaceutical developments
Journal article   Open access  Peer reviewed

Hypoxia—implications for pharmaceutical developments

Lucas DONOVAN, Scott M WELFORD, John HAAGA, Joseph LAMANNA and Kingman P STROHL
Sleep & breathing, Vol.14(4), pp.291-298
2010
PMCID: PMC3236526
PMID: 20625934

Abstract

Fundamental and applied biological sciences. Psychology Vertebrates: nervous system and sense organs Neurology Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes Development. Senescence. Regeneration. Transplantation Biological and medical sciences Medical sciences Sleep. Vigilance Nervous system (semeiology, syndromes)
url
https://doi.org/10.1007/s11325-010-0368-xView
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.102 Stem Cell Research
1.102.996 HIF-1 Alpha
Web Of Science research areas
Clinical Neurology
Respiratory System
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details